Synairgen is a respiratory drug discovery and development company founded by University of
Southampton Professors Stephen Holgate, Donna Davies and Ratko Djukanovic. The business,
focused primarily on lung viral defence in asthma and COPD, uses its differentiating human biology
BioBank platform and world-renowned international academic KOL network to discover and develop
novel therapies for respiratory disease.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.